Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma.
Maria Chiara TisiRossella PaoliniFrancesco PiazzaErika RavelliCristina TecchioRoberto SartoriBarbara FamengoEmanuele Stefano Giovanni D'AmoreGiuseppe CarliOmar PerbelliniEros Di BonaMarco RuggeriCarlo ViscoPublished in: American journal of hematology (2018)